Abstract: The invention relates to the use of a polymer P as antifoaming agent, the polymer P being a linear polymer prepared by polymerization of monomer chosen from monomer M1, monomer M2, or monomer M1 and monomer M2 monomer M1 having the following formula (I): wherein R1 and R2, independently of each other, is chosen from: —a benzyl, —a (C1-C12)alkyl group optionally substituted by a —O—(C1-C12)alkyl group, and —a (C3-C12)cycloalkyl group optionally substituted by a —O—(C1-C12)alkyl group, monomer M2 having the following formula (II): wherein R4 represents: a (C1-C12)alkyl group or a —CH2—O—R5 group, wherein R5 is chosen from: a benzyl, a (C1-C12)alkyl group optionally substituted by a —O(C1-C12)alkyl, and a (C3-C12)cycloalkyl group optionally substituted by a —O—(C1-C12)alkyl group, R3 represents a (C1-C12)alkyl group, or R3 and R4 form together, with the carbon atom bearing them, a ((C3-C12)cycloalkyl group.

Abstract: The present application relates to branched alkanes comprising n carbon atoms, n being an integer between 9 and 50, to the process for preparing same and to uses thereof. The present application also relates to the olefins for obtaining these branched alkanes.

Abstract: The present application relates to a compound of the following formula (I) in which —R1, R2, R3 and R4 represent independently of each other H or a (C1-C30) alkyl group, the total sum of the number of carbon atoms of R1, R2, R3 and R4 being equal to 6+4x, x being a whole number of between 1 and 6, provided that: at most two of the groups R1, R2, R3 and R4 are H, R5 represents H, OR, or NR?R? R, R? and R?, identical or different, represent H, a (C1-C10) alkyl group, at least one of groups R1, R2, R3 or R4 comprises or is a tertiobutyl group. (I) the method for preparing same and the uses thereof as a plasticising lubricant, surfactant or in a cosmetic composition.

Abstract: A bactericidal or bacteriostatic composition comprising an acetal or a hexitan ether preferentially of a long-chain alkyl sorbitan, arlitan or mannitan, its use in the treatment or prevention of Gram-positive bacterial infections, its use as a hygiene or dermatological product for external use and a method for disinfecting surfaces.

Abstract: The present invention relates to a A bactericidal or bacteriostatic composition comprising a deoxyhexose alkyl acetal or ether or the mixture of isomers thereof, the use thereof in treating or preventing Gram-positive bacterial infections, the use thereof as hygiene or dermatological product for external use, and also a method for disinfecting surfaces.

Abstract: The invention relates to an antimicrobial composition of monoanhydro-hexitol monoalkyl ether isomers bearing an alkyl ether radical (OR) at C-3, C-5 or C-6 of the monoanhydro-hexitol, in which the alkyl group (R) is a linear or branched, cyclic or noncyclic hydrocarbon-based group comprising between 4 to 18 carbon atoms. The invention also relates to a method for disinfecting a surface and/or equipment contaminated by bacteria, said method comprising applying to said surface or equipment to be disinfected, a composition according to the invention.

Abstract: A bactericidal or bacteriostatic composition comprising an isomer mixture of monosaccharide alkyl monoethers or monoacetals, its use in the treatment or prevention of Gram-positive bacterial infections, its use as a hygiene or dermatological product for external use and a method for disinfecting surfaces.

Abstract: A process for obtaining a mixture of C4-C8 and C9-C18 alkyl monoether of saccharide, comprising: a) a first step of acetalization or trans-acetalization of a saccharide or of a mixture of saccharides with a C4-C8 aliphatic aldehyde or the acetal thereof, b) a second consecutive or simultaneous step of acetalization or trans-acetalization of the product obtained in a) of the saccharide or mixture of saccharides with a C9-C18 aliphatic aldehyde or the acetal thereof, c) a step of catalytic hydrogenolysis of the saccharide acetals obtained, and d) a step of recovery of a mixture of C4-C8 and C9-C18 alkyl saccharide monoethers. The invention further relates to a mixture of C4-C8 and C9-C18 alkyl saccharide monoethers and the use thereof as a surfactant.

Abstract: The invention relates to an antimicrobial composition of monoanhydro-hexitol monoalkyl ether isomers bearing an alkyl ether radical (OR) at C-3, C-5 or C-6 of the monoanhydro-hexitol, in which the alkyl group (R) is a linear or branched, cyclic or noncyclic hydrocarbon-based group comprising between 4 to 18 carbon atoms. The invention also relates to a method for disinfecting a surface and/or equipment contaminated by bacteria, said method comprising applying to said surface or equipment to be disinfected, a composition according to the invention.

Abstract: A composition of monoanhydro-hexitol monoalkyl ether isomers bearing an alkyl ether radical (OR) at C-3, C-5 or C-6 of the monoanhydro-hexitol, in which the alkyl group (R) is a linear or branched, cyclic or noncyclic hydrocarbon-based group comprising between 4 to 18 carbon atoms, the process for obtaining such a composition and the use thereof as a nonionic surfactant, emulsifier, lubricant, antimicrobial agent or dispersant.

Abstract: A glazing for information display includes an assembly of two transparent inorganic or plastic sheets, connected together by a thermoplastic or adhesive interlayer or by multilayer sheets incorporating the interlayer, wherein a luminophore material is incorporated to enable the display. One of the luminophores includes a benzene ring substituted at least by: a first ester —COOR group, wherein R is a linear or branched carbon-based group including a main carbon-based chain of at least six consecutive carbon atoms, the R group including, if the chain is linear, more than 10 carbon atoms and, if the chain is branched, at least 7 carbon atoms, optionally a second —COOR? group, wherein R? is another hydrocarbon-based group or hydrogen, the second group optionally being in para position on the benzene ring with respect to the first ester group, two hydroxyl —OH groups that are optionally in para position on the benzene ring.

Abstract: A process for obtaining a mixture of C4-C8 and C9-C18 alkyl monoether of saccharide, comprising: a) a first step of acetalization or trans-acetalization of a saccharide or of a mixture of saccharides with a C4-C8 aliphatic aldehyde or the acetal thereof, b) a second consecutive or simultaneous step of acetalization or trans-acetalization of the product obtained in a) of the saccharide or mixture of saccharides with a C9-C18 aliphatic aldehyde or the acetal thereof, c) a step of catalytic hydrogenolysis of the saccharide acetals obtained, and d) a step of recovery of a mixture of C4-C8 and C9-C18 alkyl saccharide monoethers. The invention further relates to a mixture of C4-C8 and C9-C18 alkyl saccharide monoethers and the use thereof as a surfactant.

Abstract: A glazing for information display includes an assembly of at least two transparent sheets of inorganic glass or of a plastic, connected together by a thermoplastic or adhesive interlayer or by multilayer sheets incorporating such an interlayer, at least one luminophore material being incorporated into the glazing to enable the display, wherein one of the luminophores includes a benzene ring substituted at least by: two hydroxyl OH groups, a carbon-based R group, the R group including an unsaturated heterocycle, a carbon-based R? group of formula —COOR?, wherein R? is a hydrocarbon-based group or hydrogen.

Abstract: The present invention relates to a A bactericidal or bacteriostatic composition comprising an acetal or a hexitan ether preferentially of a long-chain alkyl sorbitan, arlitan or mannitan, its use in the treatment or prevention of Gram-positive bacterial infections, its use as a hygiene or dermatological product for external use and a method for disinfecting surfaces.

Abstract: A bactericidal or bacteriostatic composition comprising an isomer mixture of monosaccharide alkyl monoethers or monoacetals, its use in the treatment or prevention of Gram-positive bacterial infections, its use as a hygiene or dermatological product for external use and a method for disinfecting surfaces.

Abstract: A process for preparing a carboxylic acid, including a step of bringing at least one vicinal diol or at least one vicinal polyol into contact with an atmosphere including oxygen, and a catalyst, and in the absence of additional solvent.

Abstract: The invention relates to a drug combination comprising gaseous xenon and at least one antagonist of the NMDA receptors in a liquid or solid form for treating a disease caused by a dysfunction of the dopaminergic synaptic transmission in a human patient. The antagonist of the NMDA receptors is preferably selected from memantine, nitromemantine, amantadine and ifenprodil. The invention allows the normal function of the dopaminergic synaptic transmission of diseased neurons with an altered function to be reestablished.

Abstract: The invention relates to a drug combination including gaseous xenon and at least one NMDA receptor antagonist in liquid or solid form. In order to treat or slow tumour proliferation of cells in the contral nervous system in a human being, in particular astrocyte glia and/or the percursors thereof. The NMDA receptor antagonist is perferably memantine or altromemantine. The proportion of xenonis 10% to 80% by volume.

Abstract: A composition of monoanhydro-hexitol monoalkyl ether isomers bearing an alkyl ether radical (OR) at C-3, C-5 or C-6 of the monoanhydro-hexitol, in which the alkyl group (R) is a linear or branched, cyclic or noncyclic hydrocarbon-based group comprising between 4 to 18 carbon atoms, the process for obtaining such a composition and the use thereof as a nonionic surfactant, emulsifier, lubricant, antimicrobial agent or dispersant.

Abstract: The invention relates to a drug combination including xenon gas and at least one antioxidant, in liquid or solid form, for use in treating, slowing, or preventing neurological damage following a neurodegenerative disease in a human being. Preferably, the xenon content is 10% to 80% by volume. Also, the antioxidant is preferably vitamin E, a vitamin E analog, or a vitamin E derivative. The neurodegenerative disease is Parkinson's disease or a disease related to Parkinson's disease.